Results 131 to 140 of about 3,476 (265)
Strategic Utilization of Next-Generation Deep Brain Stimulation Pulse Generators. [PDF]
Qiu L, Spindler M, Halpern CH.
europepmc +1 more source
Diffusion–Model–Driven Discovery of Ferroelectrics for Photocurrent Applications
We developed a diffusion model–based generative AI and high‐throughput screening framework that accelerates the discovery of photovoltaic ferroelectrics. By coupling AI driven crystal generation with machine learning and DFT screening, we identified Ca3P2 and LiCdP as new ferroelectric materials exhibiting strong polarization, feasible switching ...
Byung Chul Yeo +3 more
wiley +1 more source
Universal Credit receipt among working-age patients who are accessing specialist mental health services: results from a novel data linkage study. [PDF]
Stevelink SAM +9 more
europepmc +1 more source
Peptide dendrimer–based nanoplatform with mitochondria‐targeting capability was developed for synergistic chemo‐photothermal therapy. The system promotes efficient transcytosis, induces mitochondrial dysfunction, triggers immunogenic cell death (ICD), and enhance antitumor immunity by promoting dendritic cell maturation and T‐cell activation, resulting
Min Li +15 more
wiley +1 more source
Training without jobs is a waste of aid: why Japan's partnership with the World Bank must tackle the 'fiscal space' for health workforce. [PDF]
Kubota K.
europepmc +1 more source
How the Green Architecture of the 2023-2027 Common Agricultural Policy could have been greener. [PDF]
Guyomard H +7 more
europepmc +1 more source
ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid‐β Pathology
This study identifies that ALKBH3‐driven m1A demethylation orchestrates Alzheimer's disease progression by disrupting mitochondrial and synaptic homeostasis. This epitranscriptomic mechanism suppresses PINK1‐mediated mitophagy via m1A erasure, leading to mitochondrial dysfunction, oxidative stress, elevated Aβ production, and impaired microglial ...
Yueyang Li +25 more
wiley +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source

